Press Coverage

You are here

03/20/2017

A 2014 Reshma Jagsi study of the Long-Term Impact of Chemotherapy on Breast Cancer Survivors was cited by NPR piece, "As Drug Costs Soar, People Delay Or Skip Cancer Treatments."

03/01/2017

Interim co-director, Brian Zikmund-Fisher, as well as former co-director, Angela Fagerlin, were recently featured in a Wall Street Journal article, "How to Get Patients to Take More Control of Their Medical Decisions."

02/15/2017

According to a study by Reshma Jagsi and colleagues, doctors often fail to recommend genetic testing for breast-cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers. They surveyed 2,529 breast-cancer patients and found that although two-thirds of the women reported wanting genetic testing, less than a third actually got it. About 8 in 10 women at highest risk for BRCA mutations — because of family history or ancestry — said they had wanted testing, but only a little more than half received it.

02/01/2017
Sarah Hawley and Reshma Jagsi are co-authors on two studies of the impact of doctor-patient communication on patients' perceptions of their breast cancer recurrence risk. They found that breast cancer patients commonly overestimate their risk of recurrence, which was a negative impact on their quality of life. The two studies were highlighted in a MHealth Lab Report. Brian Zikmund-Fisher was also co-author on one of these studies.
02/01/2017

Raymond De Vries' commentary, "Giving (Bits of) Your Self to Medicine" was recently published in Medicine at Michigan. He and his colleague, Tom Tomlinson (MSU), published national survey data in JAMA that showed that while most Americans are willing to donate to biobanks, they have serious concerns about how we ask for their consent and about how their donations may be used in future research.

Pages